Navigation Links
University of Wisconsin Carbone Cancer Center to Acquire ViewRay Radiation Therapy System
Date:3/9/2011

CLEVELAND, March 9, 2011 /PRNewswire/ -- The University of Wisconsin Carbone Cancer Center (UWCCC) in Madison, Wisconsin, will soon become one of the first oncology research centers to acquire a radiotherapy system from ViewRay™, Inc., a privately held medical device company. ViewRay's new research radiation therapy system features a unique combination of radiotherapy delivery and simultaneous magnetic resonance imaging (MRI). The ViewRay system is being designed to provide continuous soft-tissue MRI during treatment so that clinicians can see precisely where the radiation is being delivered.

Radiation therapy is critical in the fight against cancer, and nearly two-thirds of all cancer patients receive radiation therapy during their illness. However, natural organ motion can hinder the precision of radiation delivery to the tumor. "Patients breathe, swallow, and digest with movement of internal organs during treatment," said Paul M. Harari, MD, professor and chair of the UW Department of Human Oncology. "We plan to use the system to observe and address this problem in a new way with the use of MR imaging. Our researchers are particularly interested in studying possible applications in the treatment of thoracic, abdominal, and pelvic malignancies, where precise radiation targeting must account for organ motion."

The UWCCC is known for conducting some of the most innovative research in the field. A number of original treatment technologies have been developed at UW, particularly in the area of image-guided radiotherapy using pretreatment CT. "We have great respect for the work of UW's researchers and clinicians, and we've enjoyed a longstanding connection to the Carbone Cancer Center," said ViewRay President and CEO Gregory M. Ayers, MD, PhD. "Now the UWCCC team will lead the radiation oncology community in exploring a new way of monitoring treatments and adapting to changes in a patient's anatomy." The ViewRay system is designed to enable clinicians to plan and deliver precision radiotherapy and radiosurgery to treat lesions, tumors, and conditions anywhere in the body where radiation treatment is indicated.

ViewRay holds the exclusive worldwide license for its combination of MRI and radiotherapy technologies. Now in the late stages of development, the ViewRay system is currently available only as a non–human use research system. The company is working to secure clearance from the U.S. FDA for commercial distribution of the system for clinical use.

About ViewRay

ViewRay, Inc., of Cleveland, Ohio, is a privately held medical device company developing advanced radiation therapy technology for the treatment of cancer. Using MRI-guided radiotherapy, the ViewRay system is being designed to provide continuous soft-tissue imaging during treatment so that clinicians will be able to see where the actual radiation dose is being delivered and adapt to changes in the patient's anatomy. The system is intended to give clinicians a fresh approach to observing, assessing, and personalizing a patient's treatment. For more information, visit http://www.viewray.com.

ViewRay acknowledges the contribution of the State of Ohio, Department of Development and Third Frontier Commission, which provided funding in support of the MRI Technology Enabling Expansion of MRI into Radiotherapy Guidance Project.

About the UW Carbone Cancer Center

The University of Wisconsin Carbone Cancer Center (UWCCC) is recognized throughout the nation as one of the leading innovators in cancer research, quality patient care, teaching, and active community involvement. An integral part of the UW School of Medicine and Public Health, the UWCCC unites more than 250 physicians and scientists who work together in translating discoveries from research laboratories into new treatments that benefit cancer patients. It is the only comprehensive cancer center, as designated by the National Cancer Institute, in the state of Wisconsin. For more information, visit http://www.uwhealth.org/.

ViewRay is a trademark of ViewRay, Inc.


'/>"/>
SOURCE ViewRay, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. The University of Kansas Cancer Center and U.S. Oncology-Affiliated Kansas City Cancer Center to Merge Operations to Promote Patient Care and Research
2. Mira Dx Licenses Triple Negative Breast Cancer Risk Variant from Yale University
3. University Radiology Group Works With MedInformatix to Meet Stage 1 Meaningful Use Qualifications
4. Zell Lurie Institute Awards $106,300 to University of Michigan Students Through the Michigan Business Challenge and Dare to Dream Startup Grant Program
5. University of North Carolina Hospitals Selects Carefx Business Intelligence Dashboards To Drive Performance Improvement
6. University Hospitals Selects Allscripts Electronic Health Record for 1,400 Physicians and Expands Sunrise™ Enterprise Acute Care EHR in Eight Hospitals
7. Fairleigh Dickinson University Announces Partnership with Medco Health Solutions, Inc. for New School of Pharmacy
8. University of Southampton and Inovio Pharmaceuticals Initiate Phase 2 Clinical Study to Evaluate Leukemia DNA Vaccine Using Electroporation Delivery Technology
9. Soligenix Executes Exclusive License with the University of Colorado for Vaccine Thermostabilization Technology
10. Surgeons at University of California San Diego Perform 1st TRAM Flap Procedure in an International Multi-Center Study Using TIGR® Matrix Surgical Mesh, the Worlds 1st Long-Term Resorbable Mesh
11. EDC Functionality, Ease of Data Entry, and Access to Data All Factors in University of Virginia Cancer Centers Selection of the OnCore Clinical Research Management System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... , March 28, 2017  Akcea Therapeutics, a subsidiary ... to the company,s board of directors: ... Partners. Mr. Gabrieli will serve as chairman of the board ... former chief commercial officer of Forest Laboratories. ... Biolink Partners. "We are excited to ...
(Date:3/28/2017)... 2017 RXi Pharmaceuticals Corporation (NASDAQ: RXII), ... address significant unmet medical needs, today announced that ... Patent Office (JPO) for the composition of matter ... for the treatment or prevention of fibrotic disorders, ... proliferative retinopathy (Japanese Patent #: 6060071).  This patent ...
(Date:3/28/2017)... , March 28, 2017  Medeon Biodesign, Inc., ... company, is pleased to announce that the Company ... of Panther Orthopedics, Inc., a San ... fixation solutions for orthopedic extremity applications.  ... expand rapidly, primarily due to procedure volume growth, ...
Breaking Medicine Technology:
(Date:3/28/2017)... ... 28, 2017 , ... With expansion and efficiency in mind, Patten Seed Company ... seed processing plant opened in Marshallville in 2006, and a bagging and shipping facility ... for transition of Patten Seed operations to the Middle Georgia location from their previous ...
(Date:3/28/2017)... ... 28, 2017 , ... Oily skin is a common and unwelcomed occurrence in people of all ... lot to offer to the discussion of dealing with excess skin oil. “Oily skin is ... home remedies that can help remove the oily shine while keeping the skin fresh and ...
(Date:3/28/2017)... ... March 28, 2017 , ... Nurse ... profession as their value increases in the healthcare workforce, according to a survey ... job boards, career fairs, and candidate leads to healthcare employers of physicians and ...
(Date:3/28/2017)... ... 28, 2017 , ... Bacteria and fungi are probably not the first ingredients that come to ... the right microorganisms in your diet can actually improve health outcomes. And the good news ... the topic of a new peer-reviewed paper led by Maria Marco, Ph.D. ...
(Date:3/27/2017)... ... March 27, 2017 , ... The respected dental team ... straight teeth without the extensive time commitment and aesthetic disadvantages of traditional braces ... referral. A custom-designed series of virtually invisible aligners are created for each patient ...
Breaking Medicine News(10 mins):